Resilience is a North American contract development and manufacturing organization (CDMO) focused on delivering high-quality, scalable manufacturing solutions for advanced therapies. With capabilities spanning biologics drug substance, cell-based therapies, and aseptic drug product manufacturing for both small and large molecules, Resilience partners with leading biopharma companies to bring complex medicines to market faster and more reliably.
Leadership & Board
Current Number of Employees1,301
Current LinkedIn Followers48,143
Latest Estimated Valuation
Estimated Valuation―
Estimated Valuation―
Total Amount Raised$825M
Total Amount Raised$825M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$825M
Latest Funding Amount$825M
Latest Funding RoundInvestment
Latest Funding RoundInvestment
Post-Money Valuation―
Post-Money Valuation―
Company Momentum Positive
Articles Published on TipRanks7
Articles Published on TipRanks
7
LinkedIn Trend+0.12% followers
LinkedIn Trend
+0.12% followers
Workforce Trend+<0.1% employees
Workforce Trend
+<0.1% employees
Resilience LinkedIn following is increasing, signaling rising market interest, while its workforce is growing, indicating business expansion.
Company Momentum indicates whether the company is gaining or losing traction over time. This proprietary TipRanks metric analyzes changes in a company’s workforce and LinkedIn follower trends, balancing these signals together to generate an overall momentum sentiment.
Funding Round
Oct 29, 2025
Investment
$825.00M
―
Investors
Investment
